Business · 24/12/2014
FDA Extends Comment Period for Rare Pediatric Disease Priority Review Vouchers Program
The FDA is extending the comment period for its notice of availability, allowing interested persons more time to submit comments on the implementation of the Rare Pediatric Disease Priority Review Vouchers Program, which was first announced in November 2014.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →